Lack of association between uncoupling protein-2 Ala55Val polymorphism and incident diabetes in the atherosclerosis risk in communities study

Acta Diabetologica

Volumn 45, Issue 3, 2008, Pages 179-182

  Bielinski, Suzette J ^a   Pankow, James S ^a   Boerwinkle, Eric ^b   Bray, Molly S ^c   Kao, W H Linda ^d   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Diabetes mellitus, Type 2; Genetics; Mitochondrial uncoupling protein 2; Obesity; Polymorphism, single nucleotide

Indexed keywords

UNCOUPLING PROTEIN 2;

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR;

ALANINE; ATHEROSCLEROSIS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; INCIDENCE; ION CHANNELS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RESIDENCE CHARACTERISTICS; RISK; VALINE;

EID: 48549094813     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-008-0039-6     Document Type: Article

References (10)

1. S Krauss 2003 Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction J Clin Invest 112 12 1831 1842
2. NL Duarte 2003 A 45-bp insertion/deletion polymorphism of uncoupling protein 2 in relation to obesity in Tongans Obes Res 11 4 512 517
3. H Wang 2004 Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion Am J Physiol Endocrinol Metab 286 1 E1 7
4. X Yu 2005 The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA study Clin Chem 51 8 1451 1456
5. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol, 1989129(4):687-702
6. B Berraondo 2000 Up-regulation of muscle UCP2 gene expression by a new beta3-adrenoceptor agonist, trecadrine, in obese (cafeteria) rodents, but down-regulation in lean animals Int J Obes Relat Metab Disord 24 2 156 163
7. G Argyropoulos 1998 Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects Diabetes 47 4 685 687
8. F Krempler 2002 A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans Diabetes 51 11 3331 3335
9. DR Gable 2006 Variation in the UCP2-UCP3 gene cluster predicts the development of type 2 diabetes in healthy middle-aged men Diabetes 55 5 1504 1511
10. Kovacs P et al 2005 Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia 48 2292 2295